Nuvo Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NUVO PHARMS INC, and what generic alternatives to NUVO PHARMS INC drugs are available?
NUVO PHARMS INC has ten approved drugs.
There are four US patents protecting NUVO PHARMS INC drugs.
Summary for Nuvo Pharms Inc
| US Patents: | 4 |
| Tradenames: | 9 |
| Ingredients: | 9 |
| NDAs: | 10 |
Drugs and US Patents for Nuvo Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuvo Pharms Inc | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 207121-002 | Mar 29, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Nuvo Pharms Inc | FOLIC ACID | folic acid | TABLET;ORAL | 204418-001 | Jul 28, 2015 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Nuvo Pharms Inc | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | POWDER;ORAL, RECTAL | 204071-002 | Nov 28, 2014 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for NUVO PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Solution | 2.0% | ➤ Subscribe | 2014-06-03 |
| ➤ Subscribe | Topical Solution | 1.5% | ➤ Subscribe | 2012-07-11 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
